Wnt inhibitory factor-1 (WIF-1) has been identified as one of the secreted antagonists that bind Wnt protein. WIF-1 has been described as a tumor suppressor in various types of cancer. However, the molecular function of WIF-1 gene has never been examined in human renal cell carcinoma (RCC). Therefore, we hypothesized that WIF-1 functions as a tumor suppressor gene and overexpression of this gene may induce apoptosis and inhibit tumor growth in RCC cells. Immunohistochemistry and realtime reverse transcription-PCR revealed that WIF-1 was significantly downregulated in RCC samples and RCC cell lines, respectively.
Introduction
Renal cell carcinoma (RCC) accounts for 2% to 3% of human malignancies and is the seventh most frequent cause of tumor-dependent death among men (1) 
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Constitutive activation of the Wnt signaling pathway can be induced by deregulation of Wnt pathway members, such as overexpression of β-catenin and disheveled (4, 6). Also, downregulation of endogenous Wnt antagonists can result in unregulated Wnt signaling (9, 10) . Wnt antagonists can be divided into two functional classes, the secreted frizzled-related protein (sFRP) class and the Dickkopf (Dkk) class. Members of the sFRP class, which includes the sFRP family (sFRP-1, sFRP-2, sFRP-3, sFRP-4, and sFRP-5), WIF-1, and Cerberus, bind directly to Wnts, thereby altering their ability to bind to the Wnt receptor complex. Members of the Dkk class, which comprises certain Dkk family proteins (Dkk-1, Dkk-2, Dkk-3, and Dkk-4), inhibit Wnt signaling by binding to the LRP5/LRP6 component of the Wnt receptor complex (11) .
In normal conditions, β-catenin is controlled by the upstream regulators of the Wnt signaling pathway (12) . At the cell surface, the binding of Wnt protein with its frizzled transmembrane receptor activates disheveled phosphoprotein, which, in turn, inactivates glycogen synthase kinase-3β. The inhibited glycogen synthase kinase-3β fails to phosphorylate β-catenin, which, in turn, cannot form a complex with adenomatous polyposis coli to form an ubiquitin-mediated proteolytic complex and be degraded. Consequently, β-catenin accumulates in the cytoplasm and enters the nucleus. As a transcriptional activator, β-catenin in the nucleus binds to members of the TCF/LEF family and activates the target genes, including c-myc and cyclin D1 (13, 14) . This is a known canonical pathway of Wnt signaling.
Recently, it has become clear that gene function can be altered by epigenetic alterations. Silencing of tumor suppressor genes by hypermethylation of CpG islands within the promoter and/or 5′-regions is a common feature of human cancer and is often associated with partial or complete transcriptional block. Many (candidate) tumor suppressor genes silenced by DNA methylation have been reported for primary RCC cases and/or analyzed in RCC cell lines (15) (16) (17) .
Wnt inhibitory factor-1 (WIF-1) is highly conserved between species and was initially identified in the human retina (18) . The downregulation of WIF-1 by promoter hypermethylation has been reported in various human malignancies including carcinoma of urinary bladder (8) , lung (19) , breast (20) , esophagus (21, 22) , and stomach (23). In addition, it has been shown that WIF-1 functions as a tumor suppressor in melanoma (24), nasopharyngeal (22) , esophageal (21, 22) , stomach (23), breast (25) , and lung (26) cancers. With regard to RCC, a previous report from our laboratory showed that the methylation frequency of the Wnt antagonists could serve as biomarkers for RCC (27) , but no functional studies of the WIF-1 gene in RCC have been reported. Therefore, in the present study, we hypothesized that WIF-1 is densely methylated in its promoter region and functions as a tumor suppressor gene in RCC. To address this issue, we checked the mRNA and protein expression levels in RCC cell lines and human RCC tissues, respectively. We also overexpressed WIF-1 by nonviral gene transfer to RCC cells and examined the effect on RCC cells in vitro and tumor growth in vivo using empty vector (EV)-or WIF-1-transfected cells. In addition, apoptosis was analyzed with EV-transfected and WIF-1-transfected cells and the expression of β-catenin after gene replacement was analyzed. Immunohistochemical staining was graded on an arbitrary scale from 0 to (8, 19) . The primer sequences and PCR conditions are shown in Supplementary Table S1 . The fragment amplified corresponded to the WIF-1 promoter region −547 to +4 (the ATG start codon of WIF-1 was defined as +1). The detailed procedure for PCR was described previously (17) . The amplification products were confirmed by electrophoresis on a 2% agarose gel and sequenced directly by an outside vendor (McLab).
Materials and Methods

Immunohistochemistry
RNA extraction and reverse transcription-PCR
Transfection and colony formation assay
A human WIF-1 expression vector (pcDNA-WIF-1) was constructed by subcloning the full-length cDNA of WIF-1 (Invitrogen) with a FLAG epitope-tagged sequence into HindIII-XhoI sites of pcDNA3.1(+) vector (Invitrogen). Caki-2, ACHN, and A498 cells (1 × 10 5 per well of 6-well plate) were transfected with pcDNA-WIF-1 or with pcDNA3.1(+) vector (EV) using FuGENE HD (Roche Applied Science) according to the manufacturer's protocol. The transfected A498 cells were transferred to 10 cm cell culture dishes and selected with 400 μg/mL G418 (Invitrogen). Colonies were stained with 0.5% methylene blue 3 weeks after transfection and data were obtained from three independent experiments. Cell lines stably expressing FLAG-WIF-1 were maintained with 200 μg/mL G418. 
Cell proliferation assay
For cell proliferation assay, Caki-2, ACHN, and A498 cells were seeded in 96-well microplates at a density of 5 × 10 3 per well 24 h before transfection. After transient transfection with EV or WIF-1, cells were incubated for 144 h and cell viability was determined every 24 h by using the CellTiter 96 AQueous One Solution Cell Proliferation Assay kit (Promega) according to the manufacturer's protocol. Absorbance at 490 nm was measured with a kinetic microplate reader (Spectra MAX 190; Molecular Devices) and used as a measure of cell number. Experiments were done in quadruplicate and repeated three times. Cell proliferation assays with WIF-1 small interfering RNA were done for 72 h using the same method. For assay of stable transfectants, EV-transfected or WIF-1-transfected A498 cells were seeded at a density of 1 × 10 3 per well in 96-well microplates and incubated for 120 h. Cell viability was checked every 24 h as described above.
Apoptosis analysis
A498 cells transiently transfected with EV or WIF-1 were harvested 72 h after transfection by trypsinization and stained using an Annexin V-FITC/7-AAD KIT (Beckman Coulter) according to the manufacturer's protocol and immediately analyzed by flow cytometry (Cell Lab Quanta SC; Beckman Coulter). Experiments were done in duplicate and repeated independently three times.
Tumor growth in nude mice
All in vivo experiments were done with approval by the Animal Studies
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Functional Significance of Wnt Inhibitory Factor-1 Gene in Kidney Cancer 5/13 cancerres.aacrjournals.org/content/69/22/8603.full Subcommittee of the VAMC (protocol no. 08-003-01). Groups of six female nude mice (strain BALB/c nu/nu; Charles River Laboratories), 4 to 5 weeks old, received s.c. injections of A498-EV or A498-WIF-1 cells (1 × 10 7 in 200 μL) in the right flank area. Tumor size was determined with calipers once per week for 7 weeks, and tumor volume was calculated based on width (x) and length (y): x 2 y / 2, where x < y. After the mice were killed, tumors were resected and weighted. Tumor tissues were fixed in 10% formalin, embedded in paraffin, and stained with anti-WIF-1 antibody using the same method as described above.
Analysis of Wnt signaling activity
A498 cells (2 × 10 3 per well) were plated in 96-well plates at 24 h before transfection. A498 cells were transiently cotransfected with the TCF/LEF reporter plasmid (SABiosciences) and EV or WIF-1 according to the protocol of the manufacturer. Luciferase assays were carried out using the Dual-Luciferase Reporter Assay System (Promega) according to the manufacturer's protocol. Light emission was quantified with a TD-20/20 luminometer (Turner Biosystems). Experiments were done in triplicate and signals were normalized for transfection efficiency to the internal Renilla control.
Western analysis
Protein extraction was done with radioimmunoprecipitation assay buffer (Thermo Scientific) and the extracts (20 μg) were separated on 4% to 20% polyacrylamide gels (Thermo Scientific) and transferred to polyvinylidene fluoride (Hybond-P; GE Healthcare) membranes by electroblotting using Trans-Blot SD Semi-Dry Transfer Cell (Bio-Rad).
The membranes were blocked with 0.3% skim milk at room temperature for 1 h. Subsequently, the membranes were incubated with antibody against FLAG (Sigma-Aldrich), β-catenin (Cell Signaling), or glyceraldehyde-3-phosphate dehydrogenase (Cell Signaling) overnight. After washing, the membranes were incubated with horseradish peroxidase-linked secondary antibodies (GE Healthcare) at room temperature for 1 h. The proteins were visualized using the ECL detection system (GE Healthcare).
Statistical analysis
Data are shown as mean ± SD. The Student's t test was used to compare the two different groups. P values < 0.05 were regarded as statistically significant. All statistical analyses were done using StatView version 5.0 for Windows.
Results
Immunostaining of WIF-1 in normal human kidney and kidney cancer specimens
To examine the expression levels of WIF-1 in malignant and normal kidney tissues, immunostaining was done on a tissue microarray using antibody to WIF-1. The macroscopic appearance of the tissue microarray and typical immunostaining of WIF-1 in normal (a) and ccRCC (b) specimens (×40 and ×200) are shown in Fig. 1A . The staining was much stronger in normal specimens than in ccRCC. The mean expression score (1.955 ± 0.213) in normal specimens (n = 22) was significantly higher compared with that (0.417 ± 0.504) in ccRCC specimens (n = 24; P < 0.0001; Fig. 1B ). The methylation status at 28 CpG sites of the WIF-1 CpG island was characterized in three RCC cell lines and normal kidney DNA by bisulfite genomic sequencing ( Fig. 2A-C) . These analyses indicated that the CpG island in each cell line showed essentially the same methylation status.
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The promoter regions checked in this study of these three RCC cell lines were densely methylated, whereas the same region of normal kidney was unmethylated. In addition, we confirmed that WIF-1 expression in RCC cells was significantly restored after treatment with the demethylating agent, DAC (P < 0.05 for Caki-2 and P < 0.01 for ACHN and A498, respectively; Fig. 1D ). 
Suppression of RCC cell growth by WIF-1 transfection
To evaluate the effect of WIF-1 restoration on RCC cell growth, we transfected cells with a WIF-1-expressing pcDNA3.1(+) vector (WIF-1).
WIF-1 transcription was significantly increased at 72 h after transfection with WIF-1 but not in untreated cells or those treated with empty pcDNA3.1(+) vector (EV; P < 0.01 for all three cell lines; Supplementary   Fig. S1A and B) . The increase in WIF-1 transcription was highest in A498 cells. To examine the role of WIF-1 in RCC cell proliferation, we checked the effect of WIF-1 transfection on RCC cell viability. As shown in Fig. 3A, WIF-1 transfection decreased A498 cell viability compared with those transfected with EV. WIF-1-transfected cells were sparse and less dense than EV-transfected cells 48 and 96 h after transfection. We checked the expression levels of WIF-1 by quantitative real-time RT-PCR at 48 and 96 h after transfection in A498 cells (data not shown) and found that the expression levels were also significantly higher and almost similar to that at 72 h after transfection compared with that of EV-transfected cells ( Supplementary Fig. S1A and B) . Growth inhibition by WIF-1 transfection was also confirmed by cell proliferation assays on all three RCC cell lines. WIF-1 transfection significantly decreased RCC cell viability in a time-dependent manner (P < 0.05; Fig. 3B ). 
Promotion of apoptosis and suppression of colony formation efficiencies in RCC cells by WIF-1 transfection
We also evaluated apoptosis by using flow cytometry with A498 cells that were transiently transfected with EV or WIF-1. As shown in Fig. 3C , the apoptotic cell fractions (early apoptotic + apoptotic) were 5.09% in EVtransfected A498 cells and 20.03% in those transfected with WIF-1. Thus, WIF-1 transfection significantly induced apoptosis in A498 cells (P < 0.05 for both early apoptotic and apoptotic; Fig. 3D ). In stably transfected A498 cells, the colony formation efficiency was significantly suppressed after transfection with WIF-1 compared with that observed in EV-transfected cells (P < 0.05; Fig. 4A and B) . 
In vivo and in vitro growth using stably transfected WIF-1 cells
We made A498 stable cell lines transfected with either EV (A498-EV) or WIF-1 gene (A498-WIF-1). A498-WIF-1 cells expressed high levels of WIF-1 and showed significant inhibition of growth compared with A498-EV cells (P < 0.01; Fig. 4C and P < 0.05 for days 3-5; Fig. 4D , respectively). These cells were also used in an in vivo study using nude mice. The macroscopic appearance of tumor at day 50 after inoculation showed a larger mass in A498-EV mouse xenografts than that in A498-WIF-1 xenografts (Fig. 5A) . The average volume and weight of tumors were significantly reduced in mice injected with A498-WIF-1 cells (Fig.   5B and C, respectively) . Histologic findings from H&E staining confirmed that both xenografted tumors consisted of viable cancer cells with solid proliferation and no significant change of appearance was observed (data not shown). After 50 days, WIF-1 expression in A498-WIF-1-inoculated tumors was higher than that of A498-EV-inoculated tumors by immunohistochemistry (Fig. 5D ). There was no statistically significant difference in the body weight of the mice, nor did there appear to be any obvious toxicity from the injection (data not shown). 
Effect of WIF-1 knockdown on cell growth
To further confirm that WIF-1 functions as a tumor suppressor, WIF-1 expression in A498-WIF-1 stable cells was knocked down by RNA interference and cell proliferation assays were done. Knockdown of WIF-1 expression was verified by both quantitative and semiquantitative RT-PCR (P < 0.01; Supplementary Fig. S2A ). After WIF-1 knockdown, cell proliferation was significantly increased compared with that of cells transfected with negative control (P < 0.05 at 3 days after transfection; Supplementary Fig. S2B ).
Downregulation of Wnt signaling activity and β-catenin expression by WIF-1 transfection
To determine the effect of WIF-1 transfection on Wnt signaling activity, we 6B ) and Western blot analysis (Fig. 6C) . 
Discussion
The WIF-1 gene has been recently identified as a secreted protein that binds to Wnt proteins and inhibits their interaction with the frizzled receptor; this leads to the termination of transcription of genes activated by the β-catenin/TCF/LEF transcriptional complex (18) . Thus, it is possible that functional loss of WIF-1 results in activation of the Wnt signaling pathway, with increased proliferation and uncontrolled
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Functional Significance of Wnt Inhibitory Factor-1 Gene in Kidney Cancer 10/13 cancerres.aacrjournals.org/content/69/22/8603.full differentiation leading to carcinogenesis. To date, decreased WIF-1 mRNA and protein expression has been observed in several cancers (8, (19) (20) (21) (22) (23) (24) (25) (26) 29) . Recently, Urakami and colleagues (27) (26) reported that recombinant human WIF-1 significantly inhibited lung cancer cell growth and WIF-1 transfection significantly increased apoptotic cell death. Moreover, Ohigashi and colleagues (31) showed that overexpression of WIF-1 resulted in sensitizing PC-3 prostate cancer cells for paclitaxel to induce apoptosis. In contrast, Gumz and colleagues (30) reported that restoration of sFRP-1 significantly inhibited cell proliferation of UMRC3 RCC cells but did not promote apoptosis. Positive Wnt signaling has been reported to have antiapoptotic activity in several cell types (31-33) and our results and others suggest that WIF-1 restoration leads to increased apoptosis in several types of cancer.
Other in vivo studies on WIF-1 gene have been reported with melanoma and lung cancer (24, 26) . In those studies, WIF-1 vector along with transfection agent was injected directly into existing tumor in nude mice.
These results were similar to ours in that tumors receiving WIF-1 remained smaller, whereas tumors receiving EV grew in size. In this study, we injected cells stably transfected with either EV (A498-EV) or WIF-1 (A498-WIF-1) that showed significant differences in WIF-1 mRNA expression and growth inhibition in vitro. We found that the WIF-1-transfected xenografts showed significant growth inhibition in vivo,
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Reduced Wnt signaling activity by WIF-1 restoration has been reported in other studies (8, (21) (22) (23) (24) (25) (26) 31) . Among them, luciferase assay was done in five studies (21, (23) (24) (25) 31 ) and all showed downregulation of Wnt signaling activity. Others showed inhibition of Wnt signaling by validating the downregulation of β-catenin expression at the mRNA and/or protein levels. Similarly, we found downregulation of Wnt signaling activity and downregulation of β-catenin expression at both mRNA and protein levels, which are consistent with these previous reports. 
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